AC Immune ACIU
NASDAQ ACIU
$2.62 +0.02 (+0.77%)
At close: Sep 30, 2026 · 4:00 PM EDT

AC Immune (ACIU) Market Capitalization (2016 - 2026)

Updated

AC Immune (ACIU) posted Market Capitalization of $242.15 million for the quarter ended Jun 30, 2026, up 18.8% from $203.83 million a year earlier but down 13.5% from the prior quarter.

Analysis

AC Immune (ACIU) Market Capitalization (2016 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, AC Immune's Market Capitalization came in at $319.47 million, up 17.8% from the prior year.

  • Annual Market Capitalization shows a five-year compound annual growth rate of -3.0% (years ended Dec 2020 to Dec 2025).
  • In prior years, AC Immune's Market Capitalization was $271.11 million in the year ended Dec 31, 2024 (-45.3%), $495.99 million in the year ended Dec 31, 2023 (+190.8%), $170.59 million in the year ended Dec 31, 2022 (-58.7%) and $413.22 million in the year ended Dec 31, 2021 (+11.1%).
  • Quarterly Market Capitalization has run from a low of $170.59 million in the quarter ended Dec 31, 2022 to a high of $495.99 million in the quarter ended Dec 31, 2023 over five years.
  • On a year-over-year basis, Market Capitalization has increased in each of the last three quarters, with an average decline of 1.2% over the last eight quarters.
  • The strongest year-over-year quarter for Market Capitalization in the past five years was the quarter ended Dec 31, 2023, with growth of 190.8%; the weakest was the quarter ended Dec 31, 2022, with a decline of 58.7%.
  • According to Business Quant data, Market Capitalization for the three prior quarters was $279.79 million (quarter ended Mar 31, 2026), $319.47 million (quarter ended Dec 31, 2025) and $290.19 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 AC Immune 264.53 Mn 264.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 242.15 Mn
Mar 31, 2026 279.79 Mn
Dec 31, 2025 319.47 Mn
Sep 30, 2025 290.19 Mn
Jun 30, 2025 203.83 Mn
Mar 31, 2025 187.77 Mn
Dec 31, 2024 271.11 Mn
Sep 30, 2024 374.97 Mn
Jun 30, 2024 395.80 Mn
Mar 31, 2024 293.63 Mn
Dec 31, 2023 495.99 Mn
Sep 30, 2023 238.32 Mn
Jun 30, 2023 246.68 Mn
Mar 31, 2023 195.67 Mn
Dec 31, 2022 170.59 Mn
Sep 30, 2022 263.79 Mn
Jun 30, 2022 301.36 Mn
Mar 31, 2022 333.92 Mn
Dec 31, 2021 413.22 Mn
Sep 30, 2021 482.70 Mn
API Access

AC Immune Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=ACIU&period=max&api_key=YOUR_API_KEY